Tag
16 articles
AWS GraphRAG deployment has slashed drug research cycles by 87% by unifying fragmented databases into a single queryable knowledge graph. This advancement significantly accelerates the early stages of drug discovery and improves success rates.
British startup Orbital Assembly Corporation has launched a longevity lab into orbit to collect protein behavior data for AI training, potentially revolutionizing disease prediction and drug development.
This article explains how artificial intelligence (AI) is revolutionizing drug discovery, especially for neglected diseases. Learn how AI can speed up the process of finding new medicines and make treatments more accessible to people with rare conditions.
NVIDIA's new BioNeMo Agent Toolkit turns biomolecular models into callable AI skills, significantly boosting task completion rates in drug discovery.
OpenAI and Molecule.one demonstrate how an AI chemist using GPT-5.4 improved a key drug-making reaction, advancing medicinal chemistry research.
Reid Hoffman is leaving Microsoft’s board to focus on his AI drug discovery startup, Manus. His departure marks a shift from corporate governance to hands-on entrepreneurship.
LinkedIn co-founder Reid Hoffman has launched an AI drug discovery startup and argues that doctors should routinely seek AI second opinions, calling failure to do so 'bordering on malpractice.'
Isomorphic Labs, a DeepMind spinoff, is advancing AI-designed drugs to human trials, marking a significant milestone in pharmaceutical innovation.
Learn how artificial intelligence is revolutionizing drug discovery by helping researchers identify promising new molecules faster and more efficiently than ever before.
This article explains GPT-Rosalind, OpenAI's new domain-specific AI model for drug discovery and life sciences research, and how it represents a shift toward AI systems that enhance scientific reasoning rather than just automate tasks.
OpenAI introduces GPT-Rosalind, a specialized AI model designed to accelerate drug discovery, genomics analysis, and protein reasoning in life sciences research.
An advanced explainer of OpenAI's GPT-Rosalind, a specialized AI model designed to accelerate drug discovery and genomics research by leveraging advanced biochemistry and genomic analysis capabilities.
